European LeukemiaNet registry programme for low/INT-1 IPSS score myelodysplastic syndromes

被引：0
|
作者：
Bowen, D. [1 ]
Droste, J. [2 ]
Smith, A. [3 ]
Fenaux, P. [4 ]
Symeonidis, A. [5 ]
Sanz, G. [6 ]
Hellstrom-Lindberg, E. [7 ]
Cermak, J. [8 ]
Gologan, R. [9 ]
Germing, U. [10 ]
Stauder, R. [11 ]
Malcovati, L. [12 ]
de Witte, T. [2 ]
机构：
[1] Leeds Teaching Hosp, Leeds, W Yorkshire, England
[2] Univ Nijmegen, Nijmegen, Netherlands
[3] Univ York, York YO10 5DD, N Yorkshire, England
[4] Hop Avicenne, F-93009 Bobigny, France
[5] Univ Patras, GR-26110 Patras, Greece
[6] Hosp Univ La Fe, Valencia, Spain
[7] Karolinska Inst, Stockholm, Sweden
[8] Charles Univ Prague, Prague, Czech Republic
[9] Fundeni Clin Inst, Bucharest, Romania
[10] Univ Dusseldorf, Dusseldorf, Germany
[11] Innsbruck Med Univ, Innsbruck, Austria
[12] Univ Pavia, I-27100 Pavia, Italy
来源：
LEUKEMIA RESEARCH | 2009年 / 33卷
关键词：
D O I：
10.1016/S0145-2126(09)70095-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S66 / S67
页数：2
相关论文
共 50 条
  • [31] Lymphopenia confers poorer prognosis in Myelodysplastic Syndromes with very low and low IPSS-M
    David Fandrei
    Tony Huynh
    Marie Sébert
    Lorea Aguinaga
    Valeria Bisio
    Rathana Kim
    Emmanuelle Clappier
    Marion Espéli
    Karl Balabanian
    Hélène Moins-Teisserenc
    Antoine Toubert
    Nicolas Dulphy
    Pierre Fenaux
    Lionel Adès
    Lin-Pierre Zhao
    Blood Cancer Journal, 13
  • [32] Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group
    T M Westers
    R Ireland
    W Kern
    C Alhan
    J S Balleisen
    P Bettelheim
    K Burbury
    M Cullen
    J A Cutler
    M G Della Porta
    A M Dräger
    J Feuillard
    P Font
    U Germing
    D Haase
    U Johansson
    S Kordasti
    M R Loken
    L Malcovati
    J G te Marvelde
    S Matarraz
    T Milne
    B Moshaver
    G J Mufti
    K Ogata
    A Orfao
    A Porwit
    K Psarra
    S J Richards
    D Subirá
    V Tindell
    T Vallespi
    P Valent
    V H J van der Velden
    T M de Witte
    D A Wells
    F Zettl
    M C Béné
    A A van de Loosdrecht
    Leukemia, 2012, 26 : 1730 - 1741
  • [33] Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group
    Westers, T. M.
    Ireland, R.
    Kern, W.
    Alhan, C.
    Balleisen, J. S.
    Bettelheim, P.
    Burbury, K.
    Cullen, M.
    Cutler, J. A.
    Della Porta, M. G.
    Drager, A. M.
    Feuillard, J.
    Font, P.
    Germing, U.
    Haase, D.
    Johansson, U.
    Kordasti, S.
    Loken, M. R.
    Malcovati, L.
    te Marvelde, J. G.
    Matarraz, S.
    Milne, T.
    Moshaver, B.
    Mufti, G. J.
    Ogata, K.
    Orfao, A.
    Porwit, A.
    Psarra, K.
    Richards, S. J.
    Subira, D.
    Tindell, V.
    Vallespi, T.
    Valent, P.
    van der Velden, V. H. J.
    de Witte, T. M.
    Wells, D. A.
    Zettl, F.
    Bene, M. C.
    van de Loosdrecht, A. A.
    LEUKEMIA, 2012, 26 (07) : 1730 - 1741
  • [34] Unexpected response to erythropoietin therapy in intermediate-low IPSS myelodysplastic syndromes.
    Kwon, M.
    Ballesteros, M.
    Perez, I.
    Echeverria, V.
    Calderon, M.
    Patrignani, N.
    Escudero, A.
    Diez-Martin, Jose L.
    BLOOD, 2006, 108 (11) : 302B - 302B
  • [35] A Phase 3 Randomized Placebo (PBO)-Controlled Double-Blind Trial of Darbepoetin Alfa in the Treatment of Anemia in Patients with Low or Intermediate-1 (Int-1) Risk Myelodysplastic Syndromes (MDS)
    Platzbecker, Uwe
    Symeonidis, Argiris
    Oliva, Esther N.
    Goede, Jeroen S.
    Delforge, Michel
    Mayer, Jiri
    Slama, Borhane
    Badre, Sejal
    Gasal, Eduard
    Mehta, Bhakti
    Franklin, Janet
    BLOOD, 2016, 128 (22)
  • [36] Darbepoetin 500 mcg Q3W, alone or in combination with peg-filgrastim, in low/Int1 IPSS risk myelodysplastic syndromes unresponsive to recombinant erythropoietin
    Villani, Oreste
    Guariglia, Roberto
    Pietrantuono, Giuseppe
    Martorelli, Maria Carmen
    D'Auria, Fiorella
    Papa, Carla
    Lerose, Rosa
    Campioni, Laura
    Lanza, Francesco
    Musto, Pellegrino
    BLOOD, 2007, 110 (11) : 223B - 224B
  • [37] Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients
    U Platzbecker
    H K Al-Ali
    N Gattermann
    D Haase
    V Janzen
    J Krauter
    K Götze
    R Schlenk
    F Nolte
    A Letsch
    O G Ottmann
    A Kündgen
    M Lübbert
    U Germing
    M Wermke
    H Reinhard
    C Weiss
    K Lieder
    G Ehninger
    O Leismann
    A Giagounidis
    Leukemia, 2014, 28 : 696 - 698
  • [38] The Impact of Diabetes Mellitus As Comorbid Condition, in Patients with Lower-Risk Myelodysplastic Syndromes (MDS)- a Study of the European Leukemianet-Based MDS (EUMDS) Registry
    Symeonidis, Argiris
    Yu, Ge
    Smith, Alexandra
    Fenaux, Pierre
    Mittelman, Moshe
    Stauder, Reinhard
    Sanz, Guillermo
    Cermak, Jaroslav
    Hellstrom-Lindberg, Eva
    Malcovati, Luca
    Langemeijer, Saskia
    Germing, Ulrich
    Madry, Krzysztof
    Holm, Mette Skov
    Tatic, Aurelia
    de Almeida, Antonio Medina
    Savic, Aleksandar
    Simec, Njetocka Gredelj
    Guerci-Bresler, Agnes
    Droste, Jackie
    de Witte, T. M. M.
    Bowen, David T.
    BLOOD, 2017, 130
  • [39] TRANSFUSIONS AND PRESENCE OF RINGSIDEROBLASTS INFLUENCE HEPCIDIN AND NTBI LEVELS IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (MDS) - A REPORT FROM THE EUROPEAN LEUKEMIANET MDS REGISTRY
    de Swart, L.
    Reiniers, C.
    Bagguley, T.
    Van Marrewijk, C.
    Bowen, D.
    Cermak, J.
    Hellstrom-Lindberg, E.
    Tatic, A.
    Symeonidis, A.
    Huls, G.
    Panagiotidis, P.
    Garelius, H.
    Culligan, D.
    Krejci, M.
    Droste, J.
    Smith, A.
    Swinkels, D.
    de Witte, T.
    LEUKEMIA RESEARCH, 2015, 39 : S106 - S107
  • [40] The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk Score
    Silzle, Tobias
    Blum, Sabine
    Kasprzak, Annika
    Nachtkamp, Kathrin
    Rudelius, Martina
    Hildebrandt, Barbara
    Goetze, Katharina S.
    Gattermann, Norbert
    Lauseker, Michael
    Germing, Ulrich
    CANCERS, 2023, 15 (14)
12345